Biomarker for regulating CD4 + T cell differentiation and proliferation of type 1 diabetes mellitus and application thereof
A type 1 diabetes and biomarker technology, applied in the field of biomedicine, can solve the problems of not being able to provide T1DM intervention targets and timing, and achieve multi-possible effects
Pending Publication Date: 2022-01-14
THE AFFILIATED HOSPITAL OF QINGDAO UNIV
View PDF1 Cites 0 Cited by
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Therefore, antibody positive is only meaningful for the diagnosis of T1DM, but it cannot provide the intervention target and timing of T1DM
Method used
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View moreImage
Smart Image Click on the blue labels to locate them in the text.
Smart ImageViewing Examples
Examples
Experimental program
Comparison scheme
Effect test
Embodiment
[0019] The T1DM patients (experimental group) in this example were all inpatients in the Department of Endocrinology and Metabolism of the Affiliated Hospital of Qingdao University. The control group was healthy volunteers from the Health Examination Center of the Affiliated Hospital of Qingdao University. All subjects in the control group were excluded from the history of autoimmune diseases. and family history, the study was approved by the Ethics Committee of the Affiliated Hospital of Qingdao University and conducted in accordance with the principles of the Declaration of Helsinki.
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More PUM
Login to View More Abstract
The invention relates to the field of biomedicine, and discloses a biomarker for regulating CD4 + T cells differentiation and proliferation of type 1 diabetes mellitus, which comprises circRNA000324; the invention also discloses an application thereof. According to the invention, a new target is provided for the mechanism research of T1DM autoimmunity, a new evidence is provided for the action mechanism of non-encoding RNA (ncRNA) and related ceRNAs networks in T1DM pathogenesis, and more possibilities are provided for predicting or preventing and treating type 1 diabetes mellitus.
Description
technical field [0001] The invention relates to the field of biomedicine, in particular to a biomarker for regulating the differentiation and proliferation of CD4+ T cells in type 1 diabetes and its application. Background technique [0002] Type 1 diabetes mellitus (T1DM) is an organ-specific autoimmune disease characterized by autoreactive T cell-mediated destruction of pancreatic β-cells and insulin dysfunction, despite significant advances in research on T1DM in recent decades , but the specific mechanism of T1DM autoimmunity has not been fully determined. Although combined antibody testing including GADA, IA-A2, and ZnT8A is currently available, there are still many patients with clinical features consistent with T1DM who are negative for antibodies, and positive antibody testing in T1DM immediate relatives indicates the presence of T1DM. High-risk, immune interventions designed to target these antibodies have so far had no success. Therefore, antibody positive is onl...
Claims
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More Application Information
Patent Timeline
Login to View More Patent Type & Authority Applications(China)
IPC IPC(8): C12N15/113C12Q1/6851C12Q1/6883A61K45/00A61P3/10
CPCC12N15/113C12Q1/6851C12Q1/6883A61K45/00A61P3/10C12Q2600/158C12Q2600/178C12Q2531/113C12Q2563/107
Inventor 李树法
Owner THE AFFILIATED HOSPITAL OF QINGDAO UNIV
PatSnap Eureka turns technology decisions into work you can execute. Powered by our Innovation Knowledge Graph, it runs expert workflows across engineering, life sciences, materials and intellectual property. Get your review-ready output in minutes.
